Baricitinib for Post-HSCT Persistent Thrombocytopenia

Clinical trial NCT07535645 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07535645
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Persistent Thrombocytopenia Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2026-04-15
Primary completion: 2027-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.